Literature DB >> 18625544

Semaphorins and their receptors in lung cancer.

Vincent A Potiron1, Joëlle Roche, Harry A Drabkin.   

Abstract

Semaphorins are a large family of secreted, transmembrane and GPI-linked proteins initially characterized in the development of the nervous system and axonal guidance. Semaphorins are expressed in many tissues where they regulate normal development, organ morphogenesis, immunity and angiogenesis. They affect the cytoskeleton, actin filament organization, microtubules and cell adhesion. Semaphorin signaling is transduced by plexins, which in the case of most class-3 semaphorins requires high-affinity neuropilin receptors. The neuropilins also function as receptors for VEGF and other growth factors, and their expression is often abnormal in tumors. In cancer, semaphorins have both tumor suppressor and tumor promoting functions. We review here the current status of semaphorins and their receptors in tumor development with a focus on lung cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625544      PMCID: PMC2630718          DOI: 10.1016/j.canlet.2008.05.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  147 in total

1.  Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor.

Authors:  Mathew A von Wronski; Natarajan Raju; Radhakrishna Pillai; Nancy J Bogdan; Edmund R Marinelli; Palaniappa Nanjappan; Kondareddiar Ramalingam; Thangavel Arunachalam; Steve Eaton; Karen E Linder; Feng Yan; Sibylle Pochon; Michael F Tweedle; Adrian D Nunn
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

2.  Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.

Authors:  Arikira Matsushita; Tobias Götze; Murray Korc
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

Review 3.  Semaphorin regulation of cellular morphology.

Authors:  Tracy S Tran; Alex L Kolodkin; Rajnish Bharadwaj
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 4.  The neuropilins and their role in tumorigenesis and tumor progression.

Authors:  Noga Guttmann-Raviv; Ofra Kessler; Niva Shraga-Heled; Tali Lange; Yael Herzog; Gera Neufeld
Journal:  Cancer Lett       Date:  2006-01-08       Impact factor: 8.679

5.  Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function.

Authors:  Alfonso Catalano; Paola Caprari; Simona Moretti; Monica Faronato; Luca Tamagnone; Antonio Procopio
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

Review 6.  Targeting endothelial and tumor cells with semaphorins.

Authors:  Diane R Bielenberg; Michael Klagsbrun
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

8.  Plexin-B1 mutations in prostate cancer.

Authors:  Oscar Gee-Wan Wong; Tharani Nitkunan; Izumi Oinuma; Chun Zhou; Veronique Blanc; Richard S D Brown; Simon R J Bott; Joseph Nariculam; Gary Box; Phillipa Munson; Jason Constantinou; Mark R Feneley; Helmut Klocker; Suzanne A Eccles; Manabu Negishi; Alex Freeman; John R Masters; Magali Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

Review 9.  The semaphorins.

Authors:  Umar Yazdani; Jonathan R Terman
Journal:  Genome Biol       Date:  2006-03-30       Impact factor: 13.583

10.  Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival.

Authors:  Ling Wang; Shamit K Dutta; Tatsuyoshi Kojima; Xiaolei Xu; Roya Khosravi-Far; Stephen C Ekker; Debabrata Mukhopadhyay
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

View more
  28 in total

1.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

2.  Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.

Authors:  Samuel Bouchet; Camille Linot; Dusan Ruzic; Danica Agbaba; Benoit Fouchaq; Joëlle Roche; Katarina Nikolic; Christophe Blanquart; Philippe Bertrand
Journal:  ACS Med Chem Lett       Date:  2019-05-09       Impact factor: 4.345

3.  Inhibitory effects of Semaphorin 3F as an alternative candidate to anti-VEGF monoclonal antibody on angiogenesis.

Authors:  Gamze Tan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-16       Impact factor: 2.416

4.  Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition.

Authors:  Patrick Nasarre; Robert M Gemmill; Vincent A Potiron; Joëlle Roche; Xian Lu; Anna E Barón; Christopher Korch; Elizabeth Garrett-Mayer; Alessandro Lagana; Philip H Howe; Harry A Drabkin
Journal:  Cancer Res       Date:  2013-10-11       Impact factor: 12.701

5.  Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin.

Authors:  Matthew W Parker; Lance M Hellman; Ping Xu; Michael G Fried; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

Review 6.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

7.  Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F.

Authors:  Hou-Fu Guo; Xiaobo Li; Matthew W Parker; Johannes Waltenberger; Patrice M Becker; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2013-10-18       Impact factor: 3.162

8.  ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.

Authors:  Jonathan Clarhaut; Robert M Gemmill; Vincent A Potiron; Slimane Ait-Si-Ali; Jean Imbert; Harry A Drabkin; Joëlle Roche
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

9.  Genome wide screen identifies microsatellite markers associated with acute adverse effects following radiotherapy in cancer patients.

Authors:  Yuichi Michikawa; Tomo Suga; Atsuko Ishikawa; Hideki Hayashi; Akira Oka; Hidetoshi Inoko; Mayumi Iwakawa; Takashi Imai
Journal:  BMC Med Genet       Date:  2010-08-11       Impact factor: 2.103

Review 10.  Roles of Sema4D and Plexin-B1 in tumor progression.

Authors:  Ewe Seng Ch'ng; Atsushi Kumanogoh
Journal:  Mol Cancer       Date:  2010-09-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.